Diabetic ketoacidosis in a patient treated with olanzapine, valproic acid, and venlafaxine

South Med J. 2003 Jul;96(7):729-30. doi: 10.1097/01.SMJ.0000078649.46905.B5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Anticonvulsants / adverse effects*
  • Anticonvulsants / therapeutic use
  • Antidepressive Agents, Second-Generation / adverse effects*
  • Antidepressive Agents, Second-Generation / therapeutic use
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Benzodiazepines
  • Bipolar Disorder / drug therapy*
  • Cyclohexanols / adverse effects*
  • Cyclohexanols / therapeutic use
  • Diabetes Mellitus / chemically induced
  • Diabetes Mellitus / diagnosis
  • Diabetes Mellitus, Type 1 / chemically induced
  • Diabetes Mellitus, Type 1 / diagnosis
  • Diabetic Ketoacidosis / chemically induced*
  • Diabetic Ketoacidosis / diagnosis
  • Drug Interactions
  • Drug Therapy, Combination
  • Humans
  • Male
  • Obesity
  • Olanzapine
  • Pirenzepine / adverse effects*
  • Pirenzepine / analogs & derivatives*
  • Pirenzepine / therapeutic use
  • Risk Factors
  • Valproic Acid / adverse effects*
  • Valproic Acid / therapeutic use
  • Venlafaxine Hydrochloride

Substances

  • Anticonvulsants
  • Antidepressive Agents, Second-Generation
  • Antipsychotic Agents
  • Cyclohexanols
  • Benzodiazepines
  • Pirenzepine
  • Valproic Acid
  • Venlafaxine Hydrochloride
  • Olanzapine